Blood-based biomarkers for Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue SUPPL.1, 2014, Pages

  Chahine, Lama M ^a   Stern, Matthew B ^a   Chen Plotkin, Alice ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Blood based biomarkers; Metabolomics; Parkinson's disease; Proteomics

Indexed keywords

ALPHA SYNUCLEIN; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; DJ 1 PROTEIN; EPIDERMAL GROWTH FACTOR; URIC ACID;

ARTICLE; BLOOD ANALYSIS; DISEASE SEVERITY; FUNCTIONAL PROTEOMICS; GENE EXPRESSION PROFILING; HUMAN; METABOLOMICS; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STRUCTURAL PROTEOMICS; TRANSLATIONAL RESEARCH;

BLOOD-BASED BIOMARKERS; METABOLOMICS; PARKINSON'S DISEASE; PROTEOMICS;

BIOLOGICAL MARKERS; HUMANS; PARKINSON DISEASE;

EID: 84887923602     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/S1353-8020(13)70025-7     Document Type: Article

References (30)

1. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002, 125(Pt 4):861-870.
2. Stern MB, Lang A, Poewe W Toward a redefinition of Parkinson's disease. Mov Disord 2012, 27(1):54-60.
3. Fahn S, Elton RL Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, 153-164. Macmillan Health Care Information, Florham Park, NJ.
4. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008, 23(15):2129-2170.
5. Hoehn MM, Yahr MD Parkinsonism: onset, progression and mortality. Neurology 1967, 17(5):427-442.
6. Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, et al. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Sci Rep 2012, 2:954.
7. Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol 2008, 65(6):716-723.
8. Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, et al. Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Ann Neurol 2013, 74(1):119-127.
9. Chen-Plotkin AS, Hu WT, Siderowf A, Weintraub D, Goldmann Gross R, Hurtig HI, et al. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol 2011, 69(4):655-663.
10. Chahine LM, Qiang J, Ashbridge E, Minger J, Yearout D, Horn S, et al. Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations. JAMA Neurol 2013, 70(7):852-858.
11. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69(3):89-95.
12. Fox N, Growdon JH Biomarkers and surrogates. NeuroRx 2004, 1(2):181.
13. Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009, 132(Pt 11):2958-2969.
14. National Institute for Neurological Disorders and Stroke (NINDS) Parkinson's Disease Biomarkers Program (PDBP) (accessed September 2013). http://pdbp.ninds.nih.gov/.
15. Parkinson Progression Marker Initiative The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 2011, 95(4):629-635.
16. Shi M, Caudle WM, Zhang J Biomarker discovery in neurodegenerative diseases: a proteomic approach. Neurobiol Dis 2009, 35(2):157-164.
17. Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, Bressman SS, et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 2008, 131(Pt 2):389-396.
18. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, et al. Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A 2007, 104(3):955-960.
19. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276(5321):2045-2047.
20. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M Alpha-synuclein in Lewy bodies. Nature 1997, 388(6645):839-840.
21. El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ, et al. Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J 2003, 17(13):1945-1947.
22. Mollenhauer B, Trautmann E, Taylor P, Manninger P, Sixel-Doring F, Ebentheuer J, et al. Total CSF alpha-synuclein is lower in de novo Parkinson patients than in healthy subjects. Neurosci Lett 2013, 532:44-48.
23. Kang JH, Irwin DJ, Chen-Plotkin AS, Siderowf A, Caspell C, Coffey CS, et al. Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurol 2013 Aug 26, [Epub ahead of print].
24. El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA, et al. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J 2006, 20(3):419-425.
25. Tinsley RB, Kotschet K, Modesto D, Ng H, Wang Y, Nagley P, et al. Sensitive and specific detection of alpha-synuclein in human plasma. J Neurosci Res 2010, 88(12):2693-2700.
26. Foulds PG, Mitchell JD, Parker A, Turner R, Green G, Diggle P, et al. Phosphorylated alpha-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease. FASEB J 2011, 25(12):4127-4137.
27. Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy. J Neural Transm 2006, 113(10):1435-1439.
28. Li QX, Mok SS, Laughton KM, McLean CA, Cappai R, Masters CL, et al. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease. Exp Neurol 2007, 204(2):583-588.
29. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299(5604):256-259.
30. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain 2010, 133(Pt 3):713-726.